These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32830252)

  • 21. Impact of repeat ablation of ventricular tachycardia in patients with structural heart disease.
    Garcia Garcia J; Arya A; Dinov B; Bollmann A; Ter Bekke RMA; Vernooy K; Dagres N; Hindricks G; Darma A
    Europace; 2023 Dec; 26(1):. PubMed ID: 38127308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event.
    Stojadinović P; Wichterle D; Peichl P; Čihák R; Aldhoon B; Borišincová E; Štiavnický P; Hašková J; Ševčík A; Kautzner J
    Europace; 2024 Jun; 26(6):. PubMed ID: 38864730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
    Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
    Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease.
    Kimura Y; de Riva M; Ebert M; Glashan C; Wijnmaalen AP; Piers SR; Dekkers OM; Trines SA; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2023 Jan; 16(1):e010826. PubMed ID: 36595629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter Ablation of Ventricular Tachycardia.
    Romero J; Stevenson WG; Fujii A; Kapur S; Baldinger SH; Mehta NK; John RM; Michaud GF; Epstein LM; Koplan BA; Tedrow UB; Kumar S
    JACC Clin Electrophysiol; 2018 Jun; 4(6):810-819. PubMed ID: 29929675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.
    Tzou WS; Tung R; Frankel DS; Di Biase L; Santangeli P; Vaseghi M; Bunch TJ; Weiss JP; Tholakanahalli VN; Lakkireddy D; Vunnam R; Dickfeld T; Mathuria N; Tedrow U; Vergara P; Vakil K; Nakahara S; Burkhardt JD; Stevenson WG; Callans DJ; Della Bella P; Natale A; Shivkumar K; Marchlinski FE; Sauer WH
    Heart Rhythm; 2017 Jul; 14(7):991-997. PubMed ID: 28506710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
    ; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
    Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.
    Dinov B; Fiedler L; Schönbauer R; Bollmann A; Rolf S; Piorkowski C; Hindricks G; Arya A
    Circulation; 2014 Feb; 129(7):728-36. PubMed ID: 24211823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of catheter ablation of ventricular tachycardia: a single-center experience.
    Peichl P; Wichterle D; Pavlu L; Cihak R; Aldhoon B; Kautzner J
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):684-90. PubMed ID: 24958396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in patients with structural heart disease undergoing VT ablation.
    Darma A; Bertagnolli L; Torri F; Lurz JA; König S; Ueberham L; Bollmann A; Dagres N; Hindricks G; Dinov B; Arya A
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2675-2683. PubMed ID: 34411387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VT ablation in geriatric patients with structural heart disease: Should there still be an age limit?
    Darma A; Bertagnolli L; Dinov B; Torri F; Dagres N; Bollmann A; Hindricks G; Arya A
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):766-771. PubMed ID: 33428325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States.
    Briceño DF; Gupta T; Romero J; Kolte D; Khera S; Villablanca PA; Tran A; Mohanty S; Trivedi C; Mohanty P; Gianni C; Kim SG; Garcia M; Fonarow GC; Bhatt DL; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2018 May; 29(5):771-779. PubMed ID: 29399923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates and prognosis of early recurrence after catheter ablation for ventricular tachycardia due to structural heart disease.
    Nagashima K; Choi EK; Tedrow UB; Koplan BA; Michaud GF; John RM; Epstein LM; Tokuda M; Inada K; Kumar S; Lin KY; Barbhaiya CR; Chinitz JS; Enriquez AD; Helmbold AF; Stevenson WG
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):883-8. PubMed ID: 25136076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality?
    Dinov B; Arya A; Schratter A; Schirripa V; Fiedler L; Sommer P; Bollmann A; Rolf S; Piorkowski C; Hindricks G
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):598-605. PubMed ID: 25873719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome.
    Proietti R; Essebag V; Beardsall J; Hache P; Pantano A; Wulffhart Z; Juta R; Tsang B; Joza J; Nascimento T; Pegoraro V; Khaykin Y; Verma A
    Europace; 2015 Mar; 17(3):461-7. PubMed ID: 25488957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.
    Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A
    J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epicardial only mapping and ablation of ventricular tachycardia: a case series.
    Berte B; Yamashita S; Sacher F; Cochet H; Hooks D; Aljefairi N; Amraoui S; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P
    Europace; 2016 Feb; 18(2):267-73. PubMed ID: 25840285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventricular tachycardia arising from the aortomitral continuity in structural heart disease: characteristics and therapeutic considerations for an anatomically challenging area of origin.
    Steven D; Roberts-Thomson KC; Seiler J; Inada K; Tedrow UB; Mitchell RN; Sobieszczyk PS; Eisenhauer AC; Couper GS; Stevenson WG
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):660-6. PubMed ID: 20009078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.